Profen and Increlex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Profen (ibuprofen) and Increlex (mecasermin recombinant). Common drug interactions include sepsis among females and breath odour among males.

The phase IV clinical study analyzes what interactions people have when they take Profen and Increlex. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.

What is Increlex?

Increlex has active ingredients of mecasermin recombinant. eHealthMe is studying from 1,010 Increlex users. Check the latest studies of Increlex.



On Jul, 09, 2026

23 people who take Profen and Increlex together, and have interactions are studied.

Profen and Increlex drug interactions.

What are the common drug interactions of Profen and Increlex, by gender? *:

female:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Bacteraemia (presence of bacteria in the blood)
  3. Anorexia nervosa (psychological disorder-eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  4. Hereditary angioedema (recurrent episodes of severe swelling)
  5. Urinary tract infection
  6. Urticaria (rash of round, red welts on the skin that itch intensely)
  7. Cerebral ventricle dilatation (enlargement of ventricle of brain)
  8. Concussion (short loss of normal brain function in response to a head injury)
  9. Drug ineffective
  10. Exostosis (formation of new bone on the surface of a bone)

male:

  1. Breath odour
  2. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
  3. Vomiting
  4. Blood pressure diastolic decreased
  5. Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
  6. Disease recurrence
  7. Face oedema (swelling of face)
  8. Gastritis (inflammation of stomach)
  9. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  10. Headache (pain in head)

What are the common drug interactions of Profen and Increlex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Otitis media chronic (long lasting inflammation of the middle ear)
  2. Tonsillar hypertrophy (enlargement of the tonsils)
  3. Sinus congestion (blockage of sinus)
  4. Nasal oedema (fluid collection in nose)
  5. Swelling
  6. Blood pressure diastolic decreased
  7. Cerebral ventricle dilatation (enlargement of ventricle of brain)
  8. Disease recurrence
  9. Face oedema (swelling of face)
  10. Heart rate increased

10-19:

  1. Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
  2. Gastritis (inflammation of stomach)
  3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  4. Headache (pain in head)
  5. Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
  6. Vomiting
  7. Weight decreased

20-29:

n/a

30-39:

  1. Anorexia nervosa (psychological disorder-eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  2. Exostosis (formation of new bone on the surface of a bone)
  3. Foot deformity (functional disability of foot)
  4. Fracture
  5. Urinary tract infection

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Hereditary Angioedema (recurrent episodes of severe swelling): 9 people, 39.13%
  2. Immune System Disorder: 4 people, 17.39%
  3. Growth Hormone Deficiency: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Profen and Increlex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Profen and Increlex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Increlex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Increlex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen and mecasermin recombinant (the active ingredients of Profen and Increlex, respectively), and Profen and Increlex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: